... Hemorrhage Sevelamer Crystals Phosphate binders Dialysis End-stage renal disease Hyperphosphatemia is a common complication in advanced kidney disease and is associated with an increased risk of mortality [ 1‒5 ]. Treatment for hyperphosphatemia includes dietary modifications and initiation...

... (USRDS), patients with end-stage kidney disease (ESKD) on maintenance dialysis had higher mortality during early COVID-19 pandemic. Less is known about the effect of the pandemic on the delivery of outpatient maintenance hemodialysis and its impact on death. We examined the effect of pandemic-related...

... dialysis (AKI-D) who were ambulatory and still dependent on hemodialysis (HD) to receive treatment in outpatient dialysis facilities. This policy change generated the ongoing need to improve AKI-D care in the outpatient setting. Methods: Quality improvement study in adult patients admitted to an outpatient...

... the IL-6-to-albumin ratio (IAR) as a predictor of risk of death in incident dialysis patients. Methods: In 428 incident dialysis patients (median age 56 years, 62% men, 31% diabetes mellitus, 38% cardiovascular disease [CVD]), plasma IL-6 and albumin were measured at baseline to calculate IAR. We...

...–15% of the chronic dialysis population. We explored baseline characteristics and predictors of ESA hyporesponsiveness in a global randomized cardiovascular outcomes study comparing an investigational hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), daprodustat, with conventional ESA...

... AI Healthcare Database. Patients with KDIGO stage 2 or 3 AKI, length of stay ≥3 days, ≥3 serum creatinine measures, and no history of renal transplant, dialysis, or stage 5 chronic kidney disease were included. Patients were classified as PS-AKI (stage 3 AKI lasting ≥3 days or with death in ≤3 days...

...Vandana S. Mathur; Donald E. Wesson; Elizabeth Li; Navdeep Tangri Introduction: The percentage of patients initiating dialysis at an estimated glomerular filtration rate (eGFR) ≤9 mL/min/1.73 m 2 decreased between 2000 and 2018 in the USA. Clinical practice guidelines recommend basing the decision...

... to assess the efficacy and safety of the desidustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, against the epoetin alfa for the treatment of anemia in patients with chronic kidney disease (CKD) with dialysis dependency. Methods: DREAM-D was a phase 3, multicenter, open-label, randomized...

..., and high-sensitivity C-reactive protein (hsCRP) on coronary artery calcification (CAC) progression and mortality in incident dialysis patients without prior coronary events. Methods: A prospective cohort of incident adult dialysis participants had CAC measured by ECG-triggered multislice CT scans...

...Julia M.T. Colombijn; Anna A. Bonenkamp; Anita van Eck van der Sluijs; Joost A. Bijlsma; Arnold H. Boonstra; Akin Özyilmaz; Alferso C. Abrahams; Brigit C. van Jaarsveld; on behalf of the DOMESTICO study group Introduction: Dialysis patients are often prescribed a large number of medications...

... with cardiovascular disease. Our previous work has also demonstrated its relation to cardiac injury in dialysis patients. However, it is yet unclear whether there is an association between CXCL16 and adverse outcomes in dialysis patients. We aimed to evaluate its prognostic value along with several traditional...

..., this association has not been examined in an advanced chronic kidney disease (CKD) population. Methods: From among 102,477 US veterans transitioning to dialysis between 2007 and 2015, 21,357 patients with 2 pre-dialysis outpatient estimated glomerular filtration rates <30 mL/min/1.73 m 2 90–365 days apart...

... patients on KRT was 41% in the USA, 48% in Europe, and 60% in Japan. Dialysis is the predominant KRT in most countries, with hemodialysis being the most common modality. Variations in dialysis practice patterns account for some of the differences in survival outcomes globally. Worldwide, there is a greater...

...Anoop Sheshadri; Piyawan Kittiskulnam; Cynthia Delgado; Rebecca L. Sudore; Jennifer C. Lai; Kirsten L. Johansen Introduction: A randomized, controlled trial of a pedometer-based walking intervention with weekly activity goals led to increased walking among dialysis patients. We examined whether...

...José E. Navarrete; David C. Tong; Jason Cobb; Frederic F. Rahbari-Oskoui; Darya Hosein; Sheryl C. Caberto; Janice P. Lea; Harold A. Franch Background: End-stage kidney disease patients on dialysis are particularly susceptible to COVID-19 infection due to comorbidities, age, and logistic constraints...

... phosphorus (5.14 ± 1.37 vs. 4.89 ± 1.31, p < 0.001). Two groups did not differ in dialysis efficiency presented as single pool Kt/V ( p = 0.611). Table 1. Baseline characteristics of the subjects [email protected] 6 09 2020 6 11 2020 13 1 2021 © 2021 S. Karger AG...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Dialysis Mortality Predictors National Institutes of Health (NIH) 10.13039...

... ]. COVID-19 SARS-CoV-2 Acute kidney injury Renal replacement therapy Dialysis © 2020 S. Karger AG, Basel Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means...

... kidney disease (CKD) patients suffering from chronic pain. While opiates are frequently prescribed in non-dialysis-dependent CKD (NDD-CKD) patients, there may be toxic accumulation of metabolites, particularly among those progressing to end-stage renal disease (ESRD). We examined the association...

...) or kidney transplantation (KT). Methods: We leveraged 3 cohorts: 378 adults initiating HD (2008–2012), 4,304 adult KT candidates (2009–2019), and 1,396 KT recipients (2008–2019). The frailty phenotype was measured within 6 months of dialysis initiation, at KT evaluation, and KT admission. Prevalence...